Assenagon Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-522,578
| Closed | -$580K | – | 1488 |
|
|
2022
Q4 | $580K | Sell |
522,578
-277,713
| -35% | -$308K | ﹤0.01% | 1100 |
|
|
2022
Q3 | $1.87M | Sell |
800,291
-571,100
| -42% | -$1.34M | 0.01% | 712 |
|
|
2022
Q2 | $4.16M | Sell |
1,371,391
-92,941
| -6% | -$282K | 0.02% | 579 |
|
|
2022
Q1 | $9.94M | Buy |
1,464,332
+1,251,313
| +587% | +$8.5M | 0.03% | 346 |
|
|
2021
Q4 | $1.78M | Sell |
213,019
-24
| -0% | -$200 | 0.01% | 823 |
|
|
2021
Q3 | $1.58M | Sell |
213,043
-469,827
| -69% | -$3.49M | 0.01% | 734 |
|
|
2021
Q2 | $4.64M | Buy |
+682,870
| New | +$4.64M | 0.02% | 467 |
|
|
2019
Q3 | – | Sell |
-207,200
| Closed | -$1.03M | – | 1089 |
|
|
2019
Q2 | $1.03M | Sell |
207,200
-70,900
| -25% | -$351K | 0.01% | 673 |
|
|
2019
Q1 | $1.72M | Buy |
278,100
+230,109
| +479% | +$1.43M | 0.02% | 526 |
|
|
2018
Q4 | $162K | Buy |
+47,991
| New | +$162K | ﹤0.01% | 923 |
|